
Alzheimer’s Cortisol Study
The investigational drug was developed in response to evidence of a strong association between chronically-raised cortisol levels and the development of cognitive impairment in Alzheimer’s disease. The drug is designed to target and block production of cortisol inside brain neurons.
Preliminary Qualifications
-
You are at least 50 years old.
-
You have mild or moderate dementia, likely to be due to Alzheimers, in the opinion of the Principal Investigator.
-
You have a reliable study partner.